To identify the optimal combination of ultrasound (US) parameters for antenatal diagnosis of Lower Urinary Tract Obstructions (LUTO), as alternative to the commonly used US LUTO triad (megacystis, keyhole sign and hydronephrosis). Methods: This was a national retrospective study carried out at the eight tertiary Fetal Medicine Units (FMUs) in the Netherlands. Only cases referred antenatally because of megacystis diagnosed from the second trimester onwards and with clear final diagnosis were included in the study. The following prenatal data was collected at referral: amniotic fluid volume, hydronephrosis, renal parenchyma appearance, bladder volume, keyhole sign, ureteral size, fetal sex and gestational age (GA). A multivariate analysis was performed starting with the inclusion of all antenatal variables and excluding predictors by a backward stepwise strategy. Results: A total of 143 cases were included in the study: 124 with confirmed LUTO and 19 reclassified as non-obstructive megacystis. Receiver Operating Characteristic curve analysis identified at 35 cm 3 the optimal bladder volume cut-off for prediction of LUTO (Area Under Curve (AUC) =0.7, p=0.03). At the multivariate analysis, four variables were included in the final model: severe bladder distension (odds ratio (OR): 4.21 (95% CI, 0.98-18.21); p = 0.05), ureteral size (OR: 1.25 (95% CI, 1.02-1.54); p = 0.04), oligohydramnios (OR: 3.7 (95% CI, 0.71-19.25); p = 0.12), male sex (OR: 4.09 (95% CI, 0.88-18.88); p = 0.07) and referral before the 28th week (OR: 3.72 (95% CI, 1.18-11.72); p = 0.025). The combination of these five variables showed good accuracy in discriminating LUTO from non-obstructive megacystis (AUC=0.8, p<0.001) with better performance than the commonly used LUTO triad (AUC=0.6, p=0.07). Conclusions: A model based on five antenatal predictors showed good discriminative value in predicting LUTO, and better diagnostic accuracy compared to the classic LUTO triad. Future studies are needed to validate these results in order improve antenatal diagnosis of LUTO and prevent inappropriate fetal interventions. Objectives: Improved high-intensity focused ultrasound (HIFU) systems were clinically evaluated for the fetal therapy of twin reversed arterial perfusion sequence. Methods: HIFU transducer: We created a cooling and degassed water-circulating type HIFU transducer system and the imaging probe was set in the centre of HIFU transducer (1.1 MHz and a focal distance of 60 mm). HIFU irradiation: In this study, HIFU irradiation consists of 3 phases. The first phase is a trigger pulse (5.8 kW/cm 2 ; duration, 0.1 ms). The second phase is a continuous heating wave (1.5 kW/cm 2 ; duration, 94.5 ms). The third phase is an idle period (duration, 5.4 ms). The blood vessel of the acardiac fetus at the point where the umbilical cord entered into the body was targeted for HIFU irradiation from the maternal abdomen. Subject of this study: Case 1: A 40 y . HIFU therapy was performed at 14 weeks and 6 days of gestation. Case 2: A 32 y. HIFU therapy was performed at 14 weeks and 5 days of gestation. The ethics committee for clinical studies in the faculty of medicine in our university approved this trial and written informed consent was obtained from each patient before the study. Results: Case 1: 8 cycles of HIFU exposures were administered. HIFU exposure was stopped because the patient complained of a burning sensation during the 8th exposure. Vessel stenosis and reduced blood flow were confirmed, but occlusion was not completely confirmed. Case 2: The blood flow was occluded after the 7 cycle. The next day, the occluded vessels had recanalised. Both cases were treated with RFA subsequently and successfully delivered healthy pump fetus without any complications. Conclusions: Advantages are seen with the improved HIFU systems: the simplicity manoeuvrable and less motion range disturbance; the ability to observe in real time during exposure. Treatment interruption due to burns or complaints of heat sensation represented an obstruction on treatment completion. This remains an issue to be addressed in the future.
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